Candel Therapeutics, Inc. · NASDAQ:CADL

FMR LLC reported a 9.30% stake in Candel Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 7, 2025

FMR LLC reported a 9.30% stake in Candel Therapeutics, Inc., 3,923,599 shares, as a passive investor on Dec 31, 2024. Filed Feb 7, 2025 (Schedule 13G).

Stake
9.30%
Shares
3,923,599
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC9.30%3,923,599
Abigail P. Johnson9.30%3,923,599

Source

View original at SEC

Related